ProCE Banner Activity

Managing Progressive Hodgkin Lymphoma After High-Dose Therapy/Autologous Stem Cell Transplantation

Slideset Download
Download this expert-authored slideset from a live ASH symposium reviewing best practices and emerging strategies in managing patients with Hodgkin lymphoma who have progressed following ASCT.

Released: December 03, 2018

Expiration: December 02, 2019

Share

Faculty

Andrew M. Evens

Andrew M. Evens, DO, MSc, FACP

Professor and Chief
Division of Hematology/Oncology
Tufts Medical Center
Boston, Massachusetts

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Seagen

Takeda Oncology

Faculty Disclosure

Primary Author

Andrew M. Evens, DO, MSc, FACP

Professor and Chief
Division of Hematology/Oncology
Tufts Medical Center
Boston, Massachusetts

Andrew M. Evens, DO, MSc, FACP, has disclosed that he has received consulting fees from AbbVie, Acerta, Affimed, Bayer, Janssen, Pharmacyclics, and Seattle Genetics.